Al Hammadi Holding Company (TADAWUL:4007)
Saudi Arabia · Delayed Price · Currency is SAR 26.72
+0.22 (0.83%)
Jul 23, 2026, 3:19 PM AST
TADAWUL:4007 Financials Overview
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,252 | 1,235 | 1,154 | 1,177 | 1,122 | 951.89 |
Revenue Growth | 6.19% | 6.99% | -1.94% | 4.84% | 17.91% | 24.58% |
Gross Profit Gross Profit Growth | 366.91 | 362.33 | 382.14 | 432.6 | 419.5 | 363.78 |
Operating Income Operating Income Growth | 233.74 | 257.92 | 306.18 | 342.93 | 289.41 | 133.53 |
Net Income Net Income Growth | 224.17 | 241.86 | 338.8 | 303.33 | 257.34 | 90.09 |
Earnings Per Share EPS Growth | 1.40 | 1.51 | 2.12 | 1.90 | 1.61 | 0.56 |
EPS Growth | -35.71% | -28.61% | 11.69% | 17.87% | 185.65% | -31.14% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Services Medical Services Growth | 974.52 | 968.15 | 951.11 | 950.87 | 870.74 | 737.9 |
Pharmaceutical Products Pharmaceutical Products Growth | 277.22 | 266.38 | 202.78 | 225.89 | 251.65 | 213.99 |
Total Total Growth | 1,252 | 1,235 | 1,154 | 1,177 | 1,122 | 951.89 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 19.2 | 127.89 | 245.26 | 125.24 | 60.6 | 120.86 |
Total Debt Total Debt Growth | 279.59 | 286.41 | 304.11 | 314.15 | 361.1 | 217.2 |
Net Cash (Debt) Net Cash Growth | -260.39 | -158.51 | -58.85 | -188.91 | -300.5 | -96.34 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.63 | -0.99 | -0.37 | -1.18 | -1.88 | -0.60 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 63.3 | 213.92 | 464.07 | 350.95 | 253.31 | 434.64 |
Capital Expenditures CapEx Growth | -123.37 | -94.59 | -209.97 | -53.46 | -112.53 | -14.6 |
Free Cash Flow Free Cash Flow Growth | -60.06 | 119.33 | 254.1 | 297.5 | 140.78 | 420.03 |
Free Cash Flow Growth | - | -53.04% | -14.59% | 111.32% | -66.48% | 33.12% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 29.31% | 29.35% | 33.12% | 36.76% | 37.38% | 38.22% |
Operating Margin | 18.67% | 20.89% | 26.53% | 29.14% | 25.79% | 14.03% |
Pretax Margin | 19.23% | 20.93% | 30.74% | 27.27% | 24.43% | 12.35% |
Profit Margin | 17.91% | 19.59% | 29.36% | 25.78% | 22.93% | 9.46% |
FCF Margin | -4.80% | 9.67% | 22.02% | 25.28% | 12.54% | 44.13% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.800 | 1.100 | 1.400 | 1.400 | 1.000 | 0.750 |
Dividend Per Share Growth | -32.14% | -21.43% | 0% | 40.00% | 33.33% | 100.00% |
Dividend Yield | 2.99% | 3.99% | 3.83% | 2.55% | 2.75% | 2.83% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.07 | 18.51 | 18.14 | 31.33 | 24.93 | 53.68 |
Forward PE | 15.85 | 15.33 | 19.75 | 28.12 | 24.76 | 33.81 |
P/FCF Ratio | - | 37.52 | 24.18 | 31.95 | 45.57 | 11.51 |
PS Ratio | 3.42 | 3.63 | 5.33 | 8.08 | 5.72 | 5.08 |